Annexon (ANNX) to Release Quarterly Earnings on Tuesday

Annexon (NASDAQ:ANNX) will likely be posting its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect Annexon to post earnings of ($0.28) per share for the quarter.

Annexon (NASDAQ:ANNX) last released its earnings results on Monday, March 3rd. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.05). On average, analysts expect Annexon to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Annexon Price Performance

ANNX opened at $2.75 on Tuesday. Annexon has a 12 month low of $2.30 and a 12 month high of $8.40. The stock has a market capitalization of $301.70 million, a price-to-earnings ratio of -2.62 and a beta of 1.14. The business has a fifty day moving average price of $3.44 and a 200 day moving average price of $5.19.

Wall Street Analyst Weigh In

A number of analysts have issued reports on ANNX shares. Needham & Company LLC reaffirmed a “buy” rating and set a $16.00 price target on shares of Annexon in a report on Tuesday, March 4th. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price target on shares of Annexon in a report on Tuesday, December 17th. Six equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $15.80.

Annexon Company Profile

Annexon, Inc, a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. Its lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase II clinical trial for the treatment of amyotrophic lateral sclerosis.